Mechanistic considerations in high-throughput screening.
Copeland
Robert A
RA
Department of Enzymology and Mechanistic Pharmacology, GlaxoSmithKline, 1250 South Collegeville Road, UP1345, Collegeville, PA 19426, USA. Robert.A.Copeland@gsk.com
D004353:Drug Evaluation, Preclinical / Q000379:methods*; D004791:Enzyme Inhibitors / Q000378:metabolism / Q000494:pharmacology; D008024:Ligands; D011485:Protein Binding; D011955:Receptors, Drug / Q000037:antagonists & inhibitors / Q000378:metabolism*
D004791:Enzyme Inhibitors; D008024:Ligands; D011955:Receptors, Drug